The First Cohort homepage, information architecture organised by beat: a small bounded Today block followed by eight condition sections, each led by an evidence receipt figure

The First Cohort

Medical research, with the receipts

The lead · If you read one thing today

Investigations

A Gene-Editing Trial Killed a 6-Year-Old. Nature Published the Science and Left Her Out of the Record.

Her parents paid $860,000 to base-edit their daughter's brain. She died of an immune reaction within a week, and the published paper never says so.

Mira Petrov · 8 min read

A Gene-Editing Trial Killed a 6-Year-Old. Nature Published the Science and Left Her Out of the Record.

The published record of a base-editing trial that ended in a child's death.

Today

The 3 stories we published on 26 July. That is the whole day.

Orforglipron Reaches Deep Into the Brain's Reward Circuit and Turns the Dopamine Down
Metabolic & Weight

Orforglipron Reaches Deep Into the Brain's Reward Circuit and Turns the Dopamine Down

Sarah Okonkwo · 5 min

Pepsi Paid $1.95 Billion for Poppi, in a Category That Averages as Much Sugar as Fiber
Nutrition & Food

Pepsi Paid $1.95 Billion for Poppi, in a Category That Averages as Much Sugar as Fiber

Lena Marshall · 6 min

The Evolutionary Fix for Drug Resistance Works Best on a Tumor Too Small to Find
Cancer

The Evolutionary Fix for Drug Resistance Works Best on a Tumor Too Small to Find

Lena Marshall · 6 min

By beat

198 stories, grouped by the condition they are about. Pick your subject.

Investigations
35 articles →
A Pharma-Funded Nonprofit Is Lobbying the FDA to Kill Seven Peptides It Can't Sell You

A Pharma-Funded Nonprofit Is Lobbying the FDA to Kill Seven Peptides It Can't Sell You

NEJM Retracted the Study That Approved Amgen's Vasculitis Drug. It Had Never Done That in 200 Years.

Brain & Aging
42 articles →
The Sweeteners Sold to Diabetics as the Safe Swap Tracked With Faster Brain Aging

The Sweeteners Sold to Diabetics as the Safe Swap Tracked With Faster Brain Aging

12,772 adults, 8 years followed

Anti-Tau Alzheimer's Drugs Keep Hitting Their Target and Missing the Disease

Drugs & FDA
28 articles →
A $440,000 Drug Proved This Obesity Was Never About Willpower

A $440,000 Drug Proved This Obesity Was Never About Willpower

For Years, a Foreign Factory Could Put the Active Ingredient in Your Medicine and Never Tell the FDA

Nutrition & Food
26 articles →
The Fruit Juice Sold to Parents as the Healthy Choice Tracks With Higher Blood Pressure 25 Years Later

The Fruit Juice Sold to Parents as the Healthy Choice Tracks With Higher Blood Pressure 25 Years Later

20% higher BP risk

In the Lab, Coffee Flipped an Anti-Aging Switch. The Caffeine Barely Did.

Infectious Disease
21 articles →
Five Years After COVID, Japan Is Still Dying at Pandemic Rates, and Confirmed COVID Explains Only a Tenth

Five Years After COVID, Japan Is Still Dying at Pandemic Rates, and Confirmed COVID Explains Only a Tenth

7.55% excess deaths, 2022

The Nose-Spray TB Vaccine in Your Feed This Week Has Only Ever Worked in Mice

Metabolic & Weight
20 articles →
The GLP-1s That Barely Move the Scale Don't Cause Hair Loss, and That's the Clue Everyone Missed

The GLP-1s That Barely Move the Scale Don't Cause Hair Loss, and That's the Clue Everyone Missed

A Gut Microbe Was Feeding Ammonia to Sick Livers. A Michigan Peptide Cut Off the Supply in Monkeys.

Pregnancy Stations Killer T Cells in the Milk Ducts, and a Decade Later They Haven't Left

Pregnancy Stations Killer T Cells in the Milk Ducts, and a Decade Later They Haven't Left

Whether a T Cell Keeps Killing Cancer or Quits Is Written in How Its Genome Folds

Autoimmune & Inflammation
9 articles →
A Chinese Bark Compound Reached the Black-Box Arthritis Drugs' Pathway From Upstream, in Rats

A Chinese Bark Compound Reached the Black-Box Arthritis Drugs' Pathway From Upstream, in Rats

A Petri Dish of Angry Immune Cells, a Little Ultrasound, and a Very Big Headline

Newsletter

The Sunday Cohort

One weekly dispatch. The stories that held up.